2026-10-25
Ovintiv clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 28,436 +0.18%
S&P 7,613 +0.44%
GOLD $3,975 +1.95%
BTC $77,056 −1.52%
VIX 19.75 +1.70%
latest tape · as of 18:19 UTC
The Screen · Energy · Oil & Gas E&P
Ovintiv Inc
OVV · the NYSE · USD · Market cap $20.1B · 1,465 employees
Ovintiv Inc., together with its subsidiaries, operates as an oil and natural gas exploration and production company in North America.
Not yet scored72.62 USD
Price as of 30 Oct 2026Daily close, not a live quote
Screened 2026-10-30 · the tape above runs as of 18:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price72.62 USD at the 30 Oct 2026 close
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.08)
- Last reviewed30 Oct 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $58.50 to $88.66, base estimate $75.21 (screen dated 2026-10-30).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.08, read 2026-11-01
- Ethical screen not yet scored
Price72.62 USD
Fair value75.21
Ethical score70.0/100
Our investment reviews on this name
2026-10-14Read Accumulation63.88+13.7% to today ✓Markdown gives way to Accumulation after a 6% rise in 12 days
2026-10-02Read Markdown60.18+20.7% to today Accumulation gives way to Markdown first Markdown read since July
2026-08-08Read Accumulation59.15+22.8% to today ✓Markdown gives way to Accumulation
2026-07-02Read Markdown57.45+26.4% to today First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
Ovintiv Inc holds its Accumulation at $72.62. Consolidating, no directional conviction, held for 371 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 371 days |
| Price at the screen | $72.62 |
| Valuation | 20.21 trailing · 8.64 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.66 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 31.51% | Below 33% | Interest-bearing debt is just 31.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 1.20% | Below 33% | Cash held in interest-bearing accounts and securities is 1.2% of assets, under the one-third limit. | Pass |
| Receivables | 5.26% | Below 49% | Money owed to the company is 5.3% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Ovintiv clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-01. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Ovintiv clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 32%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. A 3.6% margin of safety to the base estimate.
Third-party analyst targets: 22 covering, consensus Buy. The average target sits +9% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $75.21, with a range of $58.50 to $88.66, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCheap oil multiples often mask cyclical traps
Picture an oil driller chasing barrels while crude prices swing like a barometer in a storm. Ovintiv trades at 8 times forward earnings with 8 percent revenue growth and a 9 percent profit margin, yet the cyclical nature of exploration and production means low multiples frequently signal peak earnings rather than bargains. A narrow moat and 7 percent return on equity add little cushion when commodity cycles turn.
The stock sits 13 percent below our fair value estimate and carries a buy consensus from analysts, but opportunity ratings stay at none. Ethical screens clear without issue, which removes one layer of concern yet does nothing to fix the underlying exposure to volatile North American energy prices.
Risk centres on the value trap. When earnings sit near cycle highs, a depressed multiple looks attractive until volumes or realisations drop and capital spending eats cash flow. Analysis, not advice.
| Forward P/E | 8.6xcheap for a company growing this fast |
| Trailing P/E | 20.2xa premium valuation |
| EPS, trailing | 3.59 |
| EPS, forward | 8.39 |
| Revenue growth | +29.7%strong top-line growth |
| Profit margin | 9.7%thin but positive margins |
| Return on equity | 8.4%a modest return on shareholder capital |
| FCF yield | 6.13% |
| Dividend yield | 209.00% |
| Debt to equity | 0.44minimal debt: a conservative balance sheet |
| Current ratio | 1.01adequate liquidity, worth monitoring |
| Beta | 0.66steadier than the market |
| Short interest, float | 0.04% |
| 52-week range | 35.47 - 73.62 |
| Moat | NARROW |
| Market cap | $20.1B |
| Employees | 1,465 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeOVV trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-01
Accumulation $72.62
+0.1% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 27% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Accumulation $72.55
+0.0% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 27% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Accumulation $72.55
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 27% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Accumulation $72.55
+0.0% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 27% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Accumulation $72.55
+0.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 27% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27
Accumulation $72.55
+9.7% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 27% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21
Accumulation $66.13
+3.5% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 24% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter.
2026-10-14
Accumulation · changed $63.88
+6.1% Entry 7
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter.
2026-10-02
Markdown · changed $60.18
-10.1% Entry 6
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 10.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter.
2026-09-08
Accumulation $66.91
+13.1% Entry 5
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 13.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $71. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Ovintiv (OVV) Upgraded to Strong Buy: What Does It Mean for the Stock? Yahoo Finance · 5d ago
- Tourmaline Oil Corp. (TRMLF) Earnings Expected to Grow: Should You Buy? Yahoo Finance · 5d ago
- Best Momentum Stocks to Buy for October 28th Yahoo Finance · 5d ago
- New Strong Buy Stocks for October 28th Yahoo Finance · 5d ago
- Has Ovintiv (OVV) Become Expensive After Its Logan Energy Deal? Yahoo Finance · 5d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
APAAPA Corporation
PRPermian Resources Holdings Inc
EXEExpand Energy
TPLTexas Pacific Land Corporation
ARAntero Resources Corp
RRCRange Resources Corporation
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Moore Rachel Maureen | EVP, Corporate Services | S - Sale | 7,753 | $490,920 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $59.09 | -1.4% | · | $986 | -1.4% |
| 2 months | $56.09 | +3.9% | · | $1,039 | +3.9% |
| 3 months | $54.63 | +6.7% | $0.30 | $1,072 | +7.2% |
| 6 months | $39.97 | +45.8% | $0.60 | $1,473 | +47.3% |
| 1 year | $38.30 | +52.2% | $1.20 | $1,553 | +55.3% |
| 2 years | $45.84 | +27.1% | $2.40 | $1,324 | +32.4% |
| 3 years | $34.68 | +68.0% | $3.60 | $1,784 | +78.4% |
| 5 years | $27.83 | +109.5% | $5.17 | $2,280 | +128.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever OVV does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.